Australian Heart Failure Practice Review: Issue 5, with commentary by Prof Andrew Coats

In this issue:

–  Guideline for the management of hypertrophic cardiomyopathy
–  Performance and quality measures for valvular and structural heart disease
–  Expert Consensus Statement on cardiac amyloidosis
–  Effect of SGLT2 inhibitors on heart failure outcomes
–  Semaglutide reduces the need for loop diuretics in heart failure
–  Vaccination against COVID-19 and clinical outcomes in heart failure
–  SEQUOIA-HCM trial in obstructive hypertrophic cardiomyopathy
–  Nurse Practitioner prescribing for empagliflozin amended
–  Lokelma approved for hyperkalaemia
–  Artificial intelligence and its role in diagnosing heart failure
–  Yoga linked to improved heart failure symptoms
–  Robot-assisted PCI

Download Australian Heart Failure Practice Review: Issue 5, with commentary by Prof Andrew Coats.